Full-Time

Data Scientist II

Outcomes Research

Posted on 10/14/2024

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Mid

Chicago, IL, USA + 1 more

More locations: United States

Hybrid role; requires some in-office presence in Chicago.

Category
Data Science
Data & Analytics
Required Skills
Data Science
R
SQL
Data Analysis
Requirements
  • Education in epidemiology, biostatistics, data science, public health, or related fields, to the level of either: PhD or Master’s degree and 3+ years of additional work experience
  • Familiar with observational real world healthcare data, including analytical experience with time-to-event methodologies
  • Analytical proficiency with claims and EHR data
  • Proven expertise in RWD analytical studies
  • Proficient in using R and SQL, especially statistical tools and packages
  • Demonstrated experience interfacing with clients, showcasing adeptness in presenting and tailoring messaging to a variety of stakeholders
  • Knowledge of oncology
  • Thrive in a fast-paced environment, with excellent project management skills
  • Proficient in navigating large, complex problems
  • Excellent written and oral communication skills, including a demonstrated ability to communicate technical concepts to non-technical stakeholders
  • Eagerness to learn and a steadfast dedication to maintaining integrity in all endeavors
Responsibilities
  • Lead independent analysis of Tempus data for RWE studies
  • Perform extensive coding and derive real-world endpoints, exhibiting deep comprehension of Tempus molecular, clinical data and 3rd party claims data
  • Interpret results of RWE analyses to draw appropriate inferences based on study design/statistical methods, while also evaluating study limitations.
  • Communicate research findings effectively to the external partner’s RWE and clinical teams, providing strategic recommendations.
  • Collaborate with internal product, engineering, oncology, bioinformatics, and clinical abstraction teams to continually enhance Tempus data quality, products and analytical best practices.
  • Stay updated on methodological advancements in real-world studies, oncology guidelines (NCCN and ongoing clinical trials) and their alignment to the evolving oncology landscape within Tempus’ database.
  • Ensure compliance with all relevant regulations and company procedures.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where they have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Unlike many competitors, Tempus combines extensive research with practical applications in patient care and drug development. The goal of Tempus is to improve healthcare delivery and outcomes by leveraging advanced data analysis and AI.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

4%

1 year growth

13%

2 year growth

34%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI adoption in healthcare aligns with Tempus' precision medicine focus.
  • Genomic testing integration into EMRs enhances data accessibility for treatment decisions.
  • Real-world data collaborations improve clinical trial efficiency and effectiveness.

What critics are saying

  • Integration challenges with OncoEMR could affect Tempus' reputation and client satisfaction.
  • Ambry Genetics acquisition may strain financial resources and distract from core operations.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids drug development by discovering novel targets and evaluating treatments.
  • Tempus' pan-cancer organoid platform enhances personalized therapeutic opportunities for cancer patients.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE